DrugPatentWatch Database Preview
Drugs in Development Information for TD-9855
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for TD-9855?
TD-9855 is an investigational drug.
There have been 9 clinical trials for TD-9855.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.
The most common disease conditions in clinical trials are Hypotension, Orthostatic, Hypotension, and Pure Autonomic Failure. The leading clinical trial sponsors are Theravance Biopharma, Theravance Biopharma R & D, Inc., and [disabled in preview].
There are fourteen US patents protecting this investigational drug and one hundred and three international patents.
Summary for TD-9855
| US Patents | 14 |
| International Patents | 103 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2019-09-01) |
| Vendors | 3 |
Recent Clinical Trials for TD-9855
| Title | Sponsor | Phase |
|---|---|---|
| Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855 | Theravance Biopharma | Phase 1 |
| Extension Study of Ampreloxetine (TD-9855) for Treating snOH in Subjects With Primary Autonomic Failure | Theravance Biopharma | Phase 3 |
| Clinical Effect Durability of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure | Theravance Biopharma | Phase 3 |
Clinical Trial Summary for TD-9855
Top disease conditions for TD-9855
Top clinical trial sponsors for TD-9855
US Patents for TD-9855
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TD-9855 | Start Trial | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| TD-9855 | Start Trial | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| TD-9855 | Start Trial | Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| TD-9855 | Start Trial | Methods for treating neurogenic orthostatic hypotension | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| TD-9855 | Start Trial | Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| TD-9855 | Start Trial | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | Theravance, Inc. (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TD-9855
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TD-9855 | Argentina | 074128 | 2028-11-14 | Start Trial |
| TD-9855 | Argentina | 074350 | 2028-11-14 | Start Trial |
| TD-9855 | Australia | 2009313948 | 2028-11-14 | Start Trial |
| TD-9855 | Australia | 2009313949 | 2028-11-14 | Start Trial |
| TD-9855 | Australia | 2009313951 | 2028-11-14 | Start Trial |
| TD-9855 | Brazil | PI0921593 | 2028-11-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
